Health
Japan to approve Moderna’s COVID-19 vaccine as soon as May 21 – Yomiuri – Nippon.com
TOKYO (Reuters) – Japanese regulators are set to approve Moderna Inc’s COVID-19 vaccine as soon as May 21,…
- Home
- News
- Japan to approve Moderna’s COVID-19 vaccine as soon as May 21 – Yomiuri
Newsfrom Japan
May 1, 2021TOKYO (Reuters) – Japanese regulators are set to approve Moderna Inc’s COVID-19 vaccine as soon as May 21, the Yomiuri Shimbun newspaper reported Saturday, without citing the source of the information.
Takeda Pharmaceutical Co, Japan’s biggest drugmaker, is handling domestic regulatory filing and imports of about 50 million doses of the Moderna shot, or enough for 25 million people. The first…
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business15 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business17 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business14 hours agoHere’s what analysts expect for the BHP share price in the coming year